Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It...
159 insider purchases on record · latest filing 2026-05-15.
Insiders have also filed 49 sale transactions at SNSE.